Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CEFUROXIME AXETIL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 140 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rakkar, S; Roberts, K; Towe, BF; Flores, SM; Heyd, A; Warner, J
      Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. Obaji, A; Sethi, S
      Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?

      DRUGS & AGING
    3. Abdel-Megeed, MA; Suh, DH; Abdel-Rahman, MS
      Intra-species extrapolation in risk assessment of different classes of antimicrobials

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    4. Talbot, GH; Kennedy, DW; Scheld, WM; Granito, K
      Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis

      CLINICAL INFECTIOUS DISEASES
    5. Ho, PL; Tse, WS; Tsang, KWT; Kwok, TK; Ng, TK; Cheng, VCC; Chan, RMT
      Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study

      CLINICAL INFECTIOUS DISEASES
    6. Gerber, MA; Tanz, RR
      New approaches to the treatment of group A streptococcal pharyngitis

      CURRENT OPINION IN PEDIATRICS
    7. Chidiac, C
      Report on bronchitis

      MEDECINE ET MALADIES INFECTIEUSES

    8. Should we use antibiotics to treat acute bronchitis in the healthy adult or acutely exacerbated chronic bronchitis in the patient without respiratorydistress syndrome

      MEDECINE ET MALADIES INFECTIEUSES

    9. Should acute bronchitis in the healthy adult or chronic bronchitis in a non respiratory deficient patient be treated by antibiotherapy? Which molecule should be used? In what type of patient?

      MEDECINE ET MALADIES INFECTIEUSES
    10. Gaillat, J; Dabernat, H
      Reassement of the Lille consensus on treatment of chronic bronchitis exacerbation

      MEDECINE ET MALADIES INFECTIEUSES
    11. Murris-Espin, M; Mazieres, J; Heurtaux, W; Leophonte, P
      Dealing with acute bronchitis in adults without pre-existing respiratory pathology - the place of short treatment - comparison of costs.

      MEDECINE ET MALADIES INFECTIEUSES
    12. Gaillat, J; Baranes, C; Amsellem, D; Cohen, A; Bougon, N; Riebbels, V; Chauveau, E
      Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.

      MEDECINE ET MALADIES INFECTIEUSES
    13. Dubreuil, C; Gehanno, P; Goldstein, F; Pancrazi, J; Timsit, C; Leblanc, F; Meunier, A; Chauveau, E
      Treatment of acute maxillary sinusitis in adult outpatients: comparison ofa five versus ten day-course of cefuroxime axetil.

      MEDECINE ET MALADIES INFECTIEUSES
    14. Dubreuil, C; Gehanno, P; Goldstein, F; Pancrazi, J; Timsit, C; Leblanc, F; Meunier, A; Chauveau, E
      Treatment of acute maxillary sinusitis in adult outpatients: comparison ofa five versus ten day-course of cefuroxime axetil

      MEDECINE ET MALADIES INFECTIEUSES
    15. Killen, BU; Corrigan, OI
      Factors influencing drug release from stearic acid based compacts

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    16. Klossek, JM; Chidiac, C; Bernard, L; Dubreuil, C; Dubreuil, L; Ferrand, PA; Gehanno, P; Goldstein, F; Salamon, R; Serrano, E; Soubrier, P; Veillon, F
      Current approaches to community-acquired acute maxillary rhinosinusitis orsinusitis in France and literature review

      RHINOLOGY
    17. Perfetto, EM; Mullins, CD; Subedi, P; Li-McLeod, J
      Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis

      CLINICAL THERAPEUTICS
    18. Gotfried, MH; DeAbate, CA; Fogarty, C; Mathew, CP; Sokol, WN
      Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

      CLINICAL THERAPEUTICS
    19. Martin, SJ; Jung, R; Garvin, CG
      A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections

      DRUG SAFETY
    20. Takata, GS; Chan, LS; Shekelle, P; Morton, SC; Mason, W; Marcy, SM
      Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media

      PEDIATRICS
    21. Rhew, DC; Weingarten, SR
      Achieving a safe and early discharge for patients with community-acquired pneumonia

      MEDICAL CLINICS OF NORTH AMERICA
    22. Gotfried, MH; Danzinger, LH; Rodvold, KA
      Seady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects

      CHEST
    23. Lamb, HM; Spencer, CM
      Management of acute otitis media - Defining the role of cefuroxime axetil

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    24. Bowman, L; Faulkner, D; Lucy, L
      Differential costs and outcomes among pediatric oral antibiotic formulations identified from a large prescription database

      JOURNAL OF CHEMOTHERAPY
    25. Temple, ME; Nahata, MC
      Pharmacotherapy of acute sinusitis in children

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    26. Rudnicka, L; Szymanska, E; Walecka, I; Slowinska, M
      Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus - A report of three cases

      DERMATOLOGY
    27. Vasu, S; Adithan, C; Shashindran, CH; Asad, M; Koumaravelou, K; Topno, I
      Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil

      INDIAN JOURNAL OF MEDICAL RESEARCH
    28. Esposito, S; Ascione, T
      Short-course treatment for acute tonsillopharyngitis

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    29. Novelli, A; Fallani, S; Cassetta, MI; Conti, S
      Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    30. Ball, P
      New antibiotics for community-acquired lower respiratory tract infections:improved activity at a cost?

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    31. San Joaquin, VH; Stull, TL
      Antibacterial agents in pediatrics

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    32. Pichichero, ME; Casey, JR; Mayes, T; Francis, AB; Marsocci, SM; Murphy, M; Hoeger, W
      Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    33. Pichichero, ME
      Short course antibiotic therapy for respiratory infections: a review of the evidence

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    34. Douadi, Y; Lescure, X; Schmit, JL
      A new antibiotic: levofloxacine

      PRESSE MEDICALE

    35. Review of the Fourth Conference on Antifectious Disease Treatment of the Societe de Pathologie Infectieuse de Langue Francaise - Management of lower airway infections

      MEDECINE ET MALADIES INFECTIEUSES
    36. Boulesteix, J; Olivier, C; Mselati, JC; Guillot, M; Chauveau, V; Bougon, N; Leblanc, F
      Lower respiratory tract infections in children: compared efficacy of cefuroxime axetil and cefpodoxime proxetil.

      MEDECINE ET MALADIES INFECTIEUSES
    37. Gehanno, P; Goldstein, F; Gutmann, L; Klossek, JM; Deschamps, V; Dubrujeaud, G
      Efficacy of twice-daily dosing of Augmentin (R) (1 g/125 mg) in acute maxillary sinusitis

      MEDECINE ET MALADIES INFECTIEUSES
    38. Ruiz-Carretero, P; Nacher, A; Merino-Sanjuan, M; Casabo, VG
      Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil inthe rat

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    39. Robson, H; Craig, DQM; Deutsch, D
      An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    40. Robson, H; Craig, DQM; Deutsch, D
      An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    41. Cubbon, MD; Masterton, RG
      New quinolones - a fresh answer to the pneumococcus

      Journal of antimicrobial chemotherapy
    42. Fogarty, CM; Bettis, RB; Griffin, TJ; Keyserling, CH; Nemeth, MA; Tack, KJ
      Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis

      Journal of antimicrobial chemotherapy
    43. Adam, D
      Short-course antibiotic therapy for infections with a single causative pathogen

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    44. Pichichero, ME
      Short courses of antibiotic in acute otitis media and sinusitis infections

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    45. Siegel, R
      How short can courses be in lower respiratory tract infections?

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    46. Janknegt, R
      Fluoroquinolones in acute exacerbation of chronic bronchitis and pneumonia- Drug selection by means of the SOJA method

      SOUTH AFRICAN MEDICAL JOURNAL
    47. Guay, DRP
      Short-course antimicrobial therapy for upper respiratory tract infections

      CLINICAL THERAPEUTICS
    48. Moreillon, P
      Endocarditis prophylaxis revisited: experimental evidence of efficacy and new Swiss recommendations

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    49. Moreno, JS; Rodriguez, J
      Use of new quinolones in respiratory tract infections

      REVISTA CLINICA ESPANOLA
    50. Schwartz, RH
      Enhancing children's satisfaction with antibiotic therapy: A taste study of several antibiotic suspensions

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    51. Laurier, C; Lachaine, J; Ducharme, A
      Economic evaluation of antibacterials in the treatment of acute sinusitis

      PHARMACOECONOMICS
    52. Pessey, JJ; Gehanno, P; Thoroddsen, E; Dagan, R; Leibovitz, E; Machac, J; Pimentel, JM; Marr, C; Leblanc, F
      Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    53. Johnson, PA; Rodriguez, HP; Wazen, JJ; Huck, W; Shan, M; Tosiello, R; Heyd, A; Echols, RM
      Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterialsinusitis

      JOURNAL OF OTOLARYNGOLOGY
    54. Robson, HJ; Craig, DQM; Deutsch, D
      An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres - Part 1: The influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    55. Al-Eidan, FA; McElnay, JC; Scott, MG; Kearney, MP; Troughton, KEU; Jenkins, J
      Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children

      Journal of antimicrobial chemotherapy
    56. Kays, MB; Wood, KK; Miles, DO
      In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri

      PHARMACOTHERAPY
    57. Read, RC
      Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia

      JOURNAL OF INFECTION
    58. Henry, DC; Sydnor, A; Settipane, GA; Allen, J; Burroughs, S; Cobb, MM; Holley, HP
      Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis

      CLINICAL THERAPEUTICS
    59. Burke, T; Villanueva, C; Mariano, H; Huck, W; Orchard, D; Haverstock, D; Heyd, A; Church, D
      Comparison of moxifloxacin and cefuroxime axetil in the treatment of acutemaxillary sinusitis

      CLINICAL THERAPEUTICS
    60. Arnez, M; Radsel-Medvescek, A; Pleterski-Rigler, D; Ruzic-Sabljic, E; Strle, F
      Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans

      WIENER KLINISCHE WOCHENSCHRIFT
    61. Dinis, PB; Monteiro, MC; Lobato, R; Martins, ML; Gomes, A
      Penetration of cefuroxime into chronically inflamed sinus mucosa

      LARYNGOSCOPE
    62. Loewen, PS; Marra, CA; Marra, F
      Systematic review of the treatment of early lyme disease

      DRUGS
    63. TURIK MA; JOHNS D
      COMPARISON OF CEFACLOR AND CEFUROXIME AXETIL IN THE TREATMENT OF ACUTE OTITIS-MEDIA WITH EFFUSION IN CHILDREN WHO FAILED AMOXICILLIN THERAPY

      Journal of chemotherapy
    64. HOPPE HL; JOHNSON CE
      OTITIS-MEDIA - FOCUS ON ANTIMICROBIAL RESISTANCE AND NEW TREATMENT OPTIONS

      American journal of health-system pharmacy
    65. PICHICHERO ME
      EVIDENCE FOR COPATHOGENICITY AS A MECHANISM FOR BACTERIAL-RESISTANCE

      Infectious diseases in clinical practice
    66. El-Bouri, KW; Lewis, AM; Okeahialam, CAJ; Wright, D; Tanna, A; Joynson, DHM
      A community outbreak of invasive and non-invasive group A beta-haemolytic streptococcal disease in a town in South Wales

      EPIDEMIOLOGY AND INFECTION
    67. Lacy, MK; Owens, RC; Xu, XW; Nicolau, DP; Quintiliani, R; Nightingale, CH
      Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    68. PICHICHERO ME; GREEN JL; FRANCIS AB; MARSOCCI SM; MURPHY AML; HOEGER W; NORIEGA C; SORRENTO A; GOOTNICK J
      RECURRENT GROUP-A STREPTOCOCCAL TONSILLOPHARYNGITIS

      The Pediatric infectious disease journal
    69. MEHRA S; VANMOERKERKE M; WELCK J; SVERRISSON G; SIROTIAKOVA J; MARR C; STALEY H
      SHORT-COURSE THERAPY WITH CEFUROXIME AXETIL FOR GROUP-A STREPTOCOCCALTONSILLOPHARYNGITIS IN CHILDREN

      The Pediatric infectious disease journal
    70. Dhote, R; Basse-Guerineau, AL; Bachmeyer, C; Christoforov, B; Assous, MV
      Treatment of Lyme disease

      PRESSE MEDICALE
    71. GEHANNO P; SEDNAOUI P; NISSEDURGEAT S
      ACUTE OTITIS-MEDIA IN ADULTS - A COMPARATIVE-STUDY OF CEFOTIAM HEXETIL AND AMOXICILLIN-CLAVULANIC ACID EFFICACY

      Medecine et maladies infectieuses
    72. GEHANNO P; PESSEY JJ; DEMONTREUIL CB; DUBREUIL C; LEVY D; BERCHE P; NALET V
      CEFATRIZINE VERSUS AMOXICILLIN-CLAVULANAT E IN ACUTE MAXILLARY SINUSITIS IN ADULTS

      Medecine et maladies infectieuses
    73. KLEIN GL; WHALEN E; ECHOLS RM; HEYD A
      CIPROFLOXACIN VERSUS CEFUROXIME AXETIL IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE BACTERIAL SINUSITIS

      Journal of otolaryngology
    74. MACGOWAN AP; BOWKER KE
      SEQUENTIAL ANTIMICROBIAL THERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS IN SEQUENTIAL THERAPY

      The Journal of infection
    75. DAJANI AS
      CURRENT THERAPY OF GROUP-A STREPTOCOCCAL PHARYNGITIS

      Pediatric annals
    76. STOECKEL K; HOFHEINZ W; LANEURY JP; DUCHENE P; SHEDLOFSKY S; BLOUIN RA
      STABILITY OF CEPHALOSPORIN PRODRUG ESTERS IN HUMAN INTESTINAL JUICE -IMPLICATIONS FOR ORAL BIOAVAILABILITY

      Antimicrobial agents and chemotherapy
    77. GENDREL D; BOURRILLON A; BINGEN E; RAYMOND J; LILIENTHAL F; TOURON D
      5-DAY-SPIRAMYCIN VS 7-DAY-PENICILLIN-V IN THE TREATMENT OF STREPTOCOCCAL TONSILLITIS IN CHILDREN

      Clinical drug investigation
    78. PERITI P
      RATIONAL CHOICE OF AN ORAL BETA-LACTAM ANTIBIOTIC

      Journal of chemotherapy
    79. SOURGENS H; DERENDORF H; SCHIFFERER H
      PHARMACOKINETIC PROFILE OF CEFACLOR

      International journal of clinical pharmacology and therapeutics
    80. DEBOCK GH; DEKKER FW; STOLK J; SPRINGER MP; KIEVIT J; VANHOUWELINGEN JC
      ANTIMICROBIAL TREATMENT IN ACUTE MAXILLARY SINUSITIS - A METAANALYSIS

      Journal of clinical epidemiology
    81. DARMSTADT GL
      ORAL ANTIBIOTIC-THERAPY FOR UNCOMPLICATED BACTERIAL SKIN INFECTIONS IN CHILDREN

      The Pediatric infectious disease journal
    82. THORODDSEN E; MARR C; EFTHYMIOPOULOS C
      CONCENTRATION OF CEFUROXIME IN MIDDLE-EAR EFFUSION OF CHILDREN WITH ACUTE OTITIS-MEDIA

      The Pediatric infectious disease journal
    83. LOW DE; DESROSIERS M; MCSHERRY J; GARBER G; WILLIAMS JW; REMY H; FENTON RS; FORTE V; BALTER M; ROTSTEIN C; CRAFT C; DUBOIS J; HARDING G; SCHLOSS M; MILLER M; MCIVOR RA; DAVIDSON RJ
      A PRACTICAL GUIDE FOR THE DIAGNOSIS AND TREATMENT OF ACUTE SINUSITIS

      CMAJ. Canadian Medical Association journal
    84. GARRAFFO R; DRUGEON HB; CHICHE D
      PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 ORAL FORMS OF CEFUROXIME AXETIL

      Fundamental and clinical pharmacology
    85. GEHANNO P; COHEN R; BARRY B
      THE TREATMENT OF ACUTE OTITIS-MEDIA - ARE ANTIBIOTICS NECESSARY - WHICH ONE FOR EMPIRIC TREATMENT - HOW LONG

      Medecine et maladies infectieuses
    86. PEYRAMOND D; RAFFI F; LUCHT F; LEBOUCHER G
      ANTIBIOTIC-TREATMENT OF PHARYNGO-TONSILLI TIS - INDICATIONS, THERAPEUTIC REGIMENS

      Medecine et maladies infectieuses
    87. DELLAMONICA P; REMAN A; CHICHE D; GILET C
      ACUTE EXACERBATION OF CHRONIC-BRONCHITIS - CEFUROXIME IM, FOLLOWED BYCEFUROXIME AXETIL VERSUS CEFTRIAXONE IM

      Medecine et maladies infectieuses
    88. CANNONI M; BONFILS P; SEDNAOUI P; SEVENIER F; JOUBERTCOLLIN M; NISSEDURGEAT S
      CEFOTIAM HEXETIL VERSUS AMOXICILLIN CLAVU LANIC ACID FOR THE TREATMENT OF CHRONIC OTITIS-MEDIA IN ADULTS/

      Medecine et maladies infectieuses
    89. BARRETT MA; LAWRENCE MJ; HUTT AJ; LANSLEY AB
      STEREOSELECTIVE ABSORPTION AND HYDROLYSIS OF CEFUROXIME AXETIL DIASTEREOMERS USING THE CACO-2 CELL MONOLAYER MODEL

      European journal of drug metabolism and pharmacokinetics
    90. CRAUSTEMANCIET S; DECROIX MO; FARINOTTI R; CHAUMEIL JC
      CEFPODOXIME-PROXETIL HYDROLYSIS AND FOOD EFFECTS IN THE INTESTINAL LUMEN BEFORE ABSORPTION - IN-VITRO COMPARISON OF RABBIT AND HUMAN MATERIAL

      International journal of pharmaceutics
    91. STEIN GE; SCHOOLEY S; WALKER RD; STRENKOSKINIX L
      PHARMACODYNAMIC ACTIVITY OF 5 ORAL CEPHALOSPORINS AGAINST HAEMOPHILUS-INFLUENZAE

      Pharmacotherapy
    92. LORENZOLAMOSA ML; CUNA M; VILAJATO JL; TORRES D; ALONSO MJ
      DEVELOPMENT OF A MICROENCAPSULATED FORM OF CEFUROXIME AXETIL USING PH-SENSITIVE ACRYLIC POLYMERS

      Journal of microencapsulation
    93. POOLE MD
      ANTIMICROBIAL THERAPY FOR SINUSITIS

      Otolaryngologic clinics of North America
    94. GHIA M; LOTTI R; TRAVERSO C; MATTIOLI F; MARTELLI A
      PENETRATION OF ORAL CEFUROXIME AXETIL INTO THE HUMAN AQUEOUS-HUMOR

      Ophthalmologica
    95. SCAGLIONE F; DEMARTINI G; ARCIDIACONO MM; PINTUCCI JP
      OPTIMUM TREATMENT OF STREPTOCOCCAL PHARYNGITIS

      Drugs
    96. VANDENBRANDE P; VONDRA V; VOGEL F; SCHLAEFFER F; STALEY H; HOLMES C
      SEQUENTIAL THERAPY WITH CEFUROXIME FOLLOWED BY CEFUROXIME AXETIL IN COMMUNITY-ACQUIRED PNEUMONIA

      Chest
    97. COLLINS JJ
      TREATMENT OF ERYTHEMA MIGRANS

      Annals of internal medicine
    98. GOOCH WM; BLAIR E; PUOPOLO A; PASTER RZ; SCHWARTZ RH; MILLER HC; SMYRE HL; YETMAN R; GIGUERE GG; COLLINS JJ
      EFFECTIVENESS OF 5 DAYS OF THERAPY WITH CEFUROXIME AXETIL SUSPENSION FOR TREATMENT OF ACUTE OTITIS-MEDIA

      The Pediatric infectious disease journal
    99. CLUZEL R; PORTIER H; MODAI J
      PREDICTIVE VALUE OF IN-VITRO SUSCEPTIBILI TY TESTING ON CLINICAL OUTCOME OF BACTERIAL PNEUMONIA TREATED WITH CEFUROXIME AXETIL

      Pathologie et biologie
    100. HUTT AJ; OGRADY J
      DRUG CHIRALITY - A CONSIDERATION OF THE SIGNIFICANCE OF THE STEREOCHEMISTRY OF ANTIMICROBIAL AGENTS

      Journal of antimicrobial chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 04:20:29